Duodenal adenocarcinoma following a neuroendocrine tumor in the duodenum
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Primary duodenal adenocarcinoma is a rare malignant neoplasm accounting for 0.3% of all gastrointestinal tract carcinomas. We herein present one case of duodenal adenocarcinoma after duodenal neuroendocrine carcinoma. Poorly differentiated duodenal neuroendocrine carcinoma with liver metastasis (TxNxM1) was confirmed, and eight cycles of palliative chemotherapy (5-fluorouracil/etoposide/cisplatin) were administered. The patient was then in a clinically complete response status. About 1 year later, newly developed adenocarcinoma was detected at the same site. It was completely surgically resected, and the patient was cured.
Abstract
Primary duodenal adenocarcinoma is a rare malignant neoplasm accounting for 0.3% of all gastrointestinal tract carcinomas. We herein present one case of duodenal adenocarcinoma after duodenal neuroendocrine carcinoma. Poorly differentiated duodenal neuroendocrine carcinoma with liver metastasis (TxNxM1) was confirmed, and eight cycles of palliative chemotherapy (5-fluorouracil/etoposide/cisplatin) were administered. The patient was then in a clinically complete response status. About 1 year later, newly developed adenocarcinoma was detected at the same site. It was completely surgically resected, and the patient was cured.
참고문헌 (9)
- Chow JS, "A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990", Int J Epidemiol, 25, pp.722~728 (1996)
- Gabos S, "Small bowel cancer in western Canada", Int J Epidemiol, 22, pp.198~206 (1993)
- Lepage C, "Incidence and management of primary malignant small bowel cancers: a well-defined French population study", Am J Gastroenterol, 101, pp.2826~2832 (2006)
- Rindi G, "Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract", Q J Nucl Med, 44, pp.13~21 (2000)
- Scherubl H, "Neuroendocrine tumors of the small bowels are on the rise: early aspects and management", World J Gastrointest Endosc, 2, pp.325~334 (2010)
- Nilsson O, "Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic)", Neuroendocrinology, 84, pp.212~215 (2006)
- Halfdanarson TR, "A single-institution experience with 491 cases of small bowel adenocarcinoma", Am J Surg, 199, pp.797~803 (2010)
- Dabaja BS, "Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients", Cancer, 101, pp.518~526 (2004)
- Zaanan A, "Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study", Ann Oncol, 21, pp.1786~1793 (2010)